The global dialyzers market value to steadily rise to an impressive US$ 13,707.2 mn by the end of 2026 from US$ 9344.7 mn in 2018, as chronic kidney diseases show an upward trend. Valuable insights into this market have been shared by Fortune Business Insights in its report, titled “Dialyzers Market Size, Share and Global Trend by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Geography Forecast till 2026”.
By Flux Type
By Usage Type
Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions andAssumptions
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.1 Prevalence of End-stageRenal Disease
4.2 Prevalence of ChronicKidney Disease
4.3 TechnologicalAdvancements in Dialyzers
4.4 Recent IndustryDevelopments such as Mergers & Acquisitions
4.5 Regulatory Scenario inKey Countries
4.6 New Products Launch
4.7 Reimbursement Scenario
4.8 Key Industry Trends
High-flux Dialyzers to be the Leading Market Segment
High-flux dialyzers are the preferred membranes in hemodialysis as they are able to efficiently remove the large-sized toxic molecules. They have been proven to restore normal kidney functions to a considerable extend. The global dialyzers market is set to benefit as the demand for high-flux membranes continues to grow throughout the forecast period.
Increasing Collaborations and Mergers to Drive Market Competition
Major participants are adopting different strategies to gain competitive edge in the global dialyzers market. These strategies include mergers and acquisitions, launching of new products, and increased investment in research and development. For example, Fresenius Medical Care recently merged with NxStage, a leader making hemodialysis machines for home use, to enhance their research capabilities in developing innovative products related to artificial intelligence and predictive analytics. Fresenius is expected to retain its position as a market leader owing to its well-established supplier network and prominent market presence.
Asia Pacific to Occupy a Significant Market Position
Generating a market revenue of US$ 3353.9 mn in 2018, Asia Pacific has emerged as a dominant region in the global dialyzers market. Rapid development of healthcare infrastructure, high prevalence of end-stage renal diseases, and growing adoption of haemodialysis are expected to keep Asia-Pacific in a leading position during the forecast period.
More Trending Topics From Fortune Business [email protected]